Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection

Lateral flow assays (lateral flow immunoassays and nucleic acid lateral flow assays) have experienced a great boom in a wide variety of early diagnostic and screening applications. As opposed to conventional examinations (High Performance Liquid Chromatography, Polymerase Chain Reaction, Gas chromat...

Full description

Bibliographic Details
Main Authors: Zidane Qriouet, Yahia Cherrah, Hassan Sefrioui, Zineb Qmichou
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/4/1058
_version_ 1827588981442740224
author Zidane Qriouet
Yahia Cherrah
Hassan Sefrioui
Zineb Qmichou
author_facet Zidane Qriouet
Yahia Cherrah
Hassan Sefrioui
Zineb Qmichou
author_sort Zidane Qriouet
collection DOAJ
description Lateral flow assays (lateral flow immunoassays and nucleic acid lateral flow assays) have experienced a great boom in a wide variety of early diagnostic and screening applications. As opposed to conventional examinations (High Performance Liquid Chromatography, Polymerase Chain Reaction, Gas chromatography-Mass Spectrometry, etc.), they obtain the results of a sample’s analysis within a short period. In resource-limited areas, these tests must be simple, reliable, and inexpensive. In this review, we outline the production process of antibodies against drugs of abuse (such as heroin, amphetamine, benzodiazepines, cannabis, etc.), used in lateral flow immunoassays as revelation or detection molecules, with a focus on the components, the principles, the formats, and the mechanisms of reaction of these assays. Further, we report the monoclonal antibody advantages over the polyclonal ones used against drugs of abuse. The perspective on aptamer use for lateral flow assay development was also discussed as a possible alternative to antibodies in view of improving the limit of detection, sensitivity, and specificity of lateral flow assays.
first_indexed 2024-03-09T00:47:14Z
format Article
id doaj.art-06bc4ee2b0f7481896e9e69981987b79
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T00:47:14Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-06bc4ee2b0f7481896e9e69981987b792023-12-11T17:27:06ZengMDPI AGMolecules1420-30492021-02-01264105810.3390/molecules26041058Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse DetectionZidane Qriouet0Yahia Cherrah1Hassan Sefrioui2Zineb Qmichou3Medical Biotechnology Center, Moroccan Foundation for Advanced Science, Innovation & Research (MAScIR), Rabat 10100, MoroccoLaboratoire de Pharmacologie et Toxicologie, Faculté de Médecine et de Pharmacie, Université Mohammed V-Souissi, Rabat 10100, MoroccoMedical Biotechnology Center, Moroccan Foundation for Advanced Science, Innovation & Research (MAScIR), Rabat 10100, MoroccoMedical Biotechnology Center, Moroccan Foundation for Advanced Science, Innovation & Research (MAScIR), Rabat 10100, MoroccoLateral flow assays (lateral flow immunoassays and nucleic acid lateral flow assays) have experienced a great boom in a wide variety of early diagnostic and screening applications. As opposed to conventional examinations (High Performance Liquid Chromatography, Polymerase Chain Reaction, Gas chromatography-Mass Spectrometry, etc.), they obtain the results of a sample’s analysis within a short period. In resource-limited areas, these tests must be simple, reliable, and inexpensive. In this review, we outline the production process of antibodies against drugs of abuse (such as heroin, amphetamine, benzodiazepines, cannabis, etc.), used in lateral flow immunoassays as revelation or detection molecules, with a focus on the components, the principles, the formats, and the mechanisms of reaction of these assays. Further, we report the monoclonal antibody advantages over the polyclonal ones used against drugs of abuse. The perspective on aptamer use for lateral flow assay development was also discussed as a possible alternative to antibodies in view of improving the limit of detection, sensitivity, and specificity of lateral flow assays.https://www.mdpi.com/1420-3049/26/4/1058drugs of abuselateral flow assay (LFA), immunochromatographymonoclonal antibodies and detection
spellingShingle Zidane Qriouet
Yahia Cherrah
Hassan Sefrioui
Zineb Qmichou
Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
Molecules
drugs of abuse
lateral flow assay (LFA), immunochromatography
monoclonal antibodies and detection
title Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
title_full Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
title_fullStr Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
title_full_unstemmed Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
title_short Monoclonal Antibodies Application in Lateral Flow Immunochromatographic Assays for Drugs of Abuse Detection
title_sort monoclonal antibodies application in lateral flow immunochromatographic assays for drugs of abuse detection
topic drugs of abuse
lateral flow assay (LFA), immunochromatography
monoclonal antibodies and detection
url https://www.mdpi.com/1420-3049/26/4/1058
work_keys_str_mv AT zidaneqriouet monoclonalantibodiesapplicationinlateralflowimmunochromatographicassaysfordrugsofabusedetection
AT yahiacherrah monoclonalantibodiesapplicationinlateralflowimmunochromatographicassaysfordrugsofabusedetection
AT hassansefrioui monoclonalantibodiesapplicationinlateralflowimmunochromatographicassaysfordrugsofabusedetection
AT zinebqmichou monoclonalantibodiesapplicationinlateralflowimmunochromatographicassaysfordrugsofabusedetection